|
Characterization of a novel RNA-guided endoRNAse and applications towards genome-wide screening for non-coding RNA roles in melanoma resistance
|
5F30CA210382-02
|
$49,524
|
ABUDAYYEH, OMAR
|
HARVARD MEDICAL SCHOOL
|
|
Role of Nix in pancreatic ductal adenocarcinoma
|
5F30CA200240-03
|
$49,524
|
ALAGESAN, BRINDA
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
|
5F30CA220847-02
|
$49,524
|
ALI, MOIEZ
|
DUKE UNIVERSITY
|
|
Sensitization to CD47 Blockade to Enhance Anti-Tumor Immunity
|
5F30CA195973-04
|
$49,524
|
ANDERSON, KATIE
|
UNIVERSITY OF MINNESOTA
|
|
Clinical bacterial isolate engineered as an immunotherapy for prostate cancer
|
5F30CA203472-03
|
$49,524
|
ANKER, JONATHAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Targeting the Major Histocompatibility Class I-LILRB1 signaling axis for cancer immunotherapy by macrophages
|
1F30CA232472-01
|
$43,039
|
BARKAL, AMIRA
|
STANFORD UNIVERSITY
|
|
Uncovering the role of individual RNA helicases in cancer through specific chemical inhibition
|
5F30CA203522-03
|
$49,524
|
BARKOVICH, KRISTER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Oxygen impact on tumor metastasis dormancy and therapy
|
5F30CA199947-03
|
$49,524
|
BECKWITT, COLIN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Investigating the Relationship Between Racial Residential Segregation and Hepatocellular Carcinoma
|
1F30CA216947-01A1
|
$49,524
|
BEMANIAN, AMIN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Investigating the role of the mitochondrial pyruvate carrier in colon tumorigenesis
|
1F30CA225110-01
|
$44,061
|
BENSARD, CLAIRE
|
UNIVERSITY OF UTAH
|
|
The sequence recognition, structure and function of the IMP family of mRNA binding proteins
|
5F30CA214009-02
|
$49,524
|
BISWAS, JEETAYU
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Elucidating the Mechanisms by which Hexokinase 2 Regulates Breast Cancer Metastasis
|
1F30CA228191-01
|
$49,524
|
BLAHA, CATHERINE
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
The role of paracrine WNT5A/RYK in ErbB2-driven tumorigenesis
|
5F30CA206255-02
|
$34,447
|
BORCHERDING, NICHOLAS
|
UNIVERSITY OF IOWA
|
|
Defining and translating the properties that sustain the antitumor efficacy of Th17 cells
|
5F30CA200272-04
|
$46,154
|
BOWERS, JACOB
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Role of Oncometabolite L-2 Hydroxyglutarate in Reprogramming Renal Cell Carcinoma Metabolism
|
1F30CA232397-01
|
$37,434
|
BRINKLEY, GARRETT
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
The Role of Leukocytes in the Hypothalamus in Cancer Cachexia
|
1F30CA213745-01A1
|
$49,524
|
BURFEIND, KEVIN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Mechanisms of Macrophage-Mediated Tumor Metastasis
|
5F30CA200133-05
|
$36,016
|
BURKARD, LAUREN
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Metabolic Resistance to Hypoxia in Glioblastoma Multiforme
|
1F30CA225143-01
|
$32,912
|
CAFLISCH, LAURA
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
Translational dysregulation of cell fate regulators drives oncogenic growth
|
1F30CA224951-01A1
|
$38,976
|
CAI, YI
|
UNIVERSITY OF WASHINGTON
|
|
Dissecting the Ecology of Metastasis in a Zebrafish Model: Trade-Offs of Size and Diversity in Circulating Tumor Cell Clusters
|
1F30CA220954-01A1
|
$45,891
|
CAMPBELL, NATHANIEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
CXCR3 in Pancreatic Cancer Progression and Metastasis
|
1F30CA225117-01
|
$33,026
|
CANNON, ANDREW
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
A CD47-blocking oncolytic vaccinia virus for cancer therapy
|
5F30CA203270-03
|
$44,524
|
CAO, FELICIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Phosphotyrosine-mimicking peptides for the inhibition of the Src Homology 2 (SH2) Domain of the Signal Transducer and Activator of Transcription 3 (STAT3)
|
5F30CA220678-02
|
$40,264
|
CERULLI, ROBERT
|
TUFTS UNIVERSITY BOSTON
|
|
AMPK Regulation of Microtubule Dynamics in Breast Cancer Metastasis
|
5F30CA196075-04
|
$37,843
|
CHAKRABARTI, KRISTI
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Defining the quantitative relationship between DNA damage and cell cycle dynamics in CUL9-deficient cells
|
5F30CA213876-02
|
$35,485
|
CHAO, HUI XIAO
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Using CRISPR/Cas9 to dissect the role of FUS-CHOP in tumor response to radiation therapy
|
5F30CA206424-03
|
$38,124
|
CHEN, MARK
|
DUKE UNIVERSITY
|
|
Mechanistic studies of genomic RNA dimerization in an oncoretrovirus
|
5F30CA214010-02
|
$31,037
|
CHEN, EUNICE
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
HIV-1 Vif in AIDS-Related Malignancies
|
5F30CA200432-04
|
$38,339
|
CHENG, ADAM
|
UNIVERSITY OF MINNESOTA
|
|
Identifying novel effectors of oncogenic Kras in pancreatic cells via proximity labelling
|
5F30CA213883-02
|
$34,319
|
CHENG, DEREK
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Using [6-13C,6-15N3]-L-Arginine for the molecular imaging of in vivo tumor arginase flux, and towards understanding the role of arginase isoforms in cancer metabolism.
|
1F30CA225174-01
|
$45,891
|
CHO, ANDREW
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Novel PD-L1 signals regulating anti-tumor immunity and immunotherapy responses
|
5F30CA206398-03
|
$40,028
|
CLARK, CURTIS
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
Investigating the Role of the Tumor MicroEnvironment in Resistance of Urothelial Carcinoma of the Bladder to FGFR3 Inhibition
|
5F30CA206333-02
|
$49,524
|
CLAUNCH-RABE, CHERYL
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
The Role of CD147 in Glioblastoma Invasiveness
|
5F30CA206389-02
|
$38,602
|
COLANGELO, NICHOLAS
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
The cyclic AMP/phosphodiesterase4 axis regulates proximal B cell receptor signaling and offers a new therapeutic strategy for B cell lymphomas
|
5F30CA206343-03
|
$40,028
|
COONEY, JEFFREY
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
Engineering Reversible Cell-Cell Interactions with Chemically Self-Assembled CARs
|
5F30CA210345-03
|
$44,013
|
CSIZMAR, CLIFFORD
|
UNIVERSITY OF MINNESOTA
|
|
Mast cell mediators augment the immunoregulatory function of MDSCs.
|
5F30CA192836-04
|
$42,942
|
DAMLE, SHEELA
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Dual Targeting Cytosolic and Mitochondrial One-Carbon Metabolism with Novel 5-substituted Pyrrolopyrimidines
|
1F30CA228221-01
|
$42,124
|
DEKHNE, AAMOD
|
WAYNE STATE UNIVERSITY
|
|
Evaluation of Bruton's Tyrosine Kinase and p110 delta in Mutant Shp2-Induced JMML
|
5F30CA210518-03
|
$49,524
|
DENG, LISA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Identifying causes and consequences of centrosome amplification in cancer
|
5F30CA203271-03
|
$36,702
|
DENU, RYAN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Therapeutic and Sustained Cytokine Delivery at the Tumor Site Using Engineered Mononuclear Cells
|
5F30CA203325-03
|
$38,249
|
DONAHUE, PATRICK
|
NORTHWESTERN UNIVERSITY
|
|
The Effects of Obesity on the Efficacy of Immunotherapy
|
1F30CA224559-01
|
$29,204
|
DUDZINSKI, STEPHANIE
|
VANDERBILT UNIVERSITY
|
|
Immunologic Targeting of Developmentally-Regulated Antigens for the Treatment of High-Risk Medulloblastoma
|
5F30CA221345-02
|
$40,126
|
DYSON, KYLE
|
UNIVERSITY OF FLORIDA
|
|
Genome-scale CRISPR activation screening to identify lung-specific metastatic pathways
|
1F30CA232407-01
|
$35,761
|
EBRIGHT, RICHARD
|
HARVARD MEDICAL SCHOOL
|
|
Integrin Function in Breast Cancer Initiation
|
5F30CA206271-03
|
$29,167
|
ELAIMY, AMEER
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Bile Acid-Mediated IQGAP1 Regulation Drives Hepatic Tumorigenesis
|
1F30CA206495-01A1
|
$45,271
|
ERICKSON, HANNA
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
The effect of cancer-associated SETD2 mutations on transcription and chromatin organization
|
5F30CA192643-04
|
$40,541
|
FAHEY, CATHERINE
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Targeting lung and breast cancer cell oxidative metabolism with D-penicillamine and disulfiram
|
5F30CA213817-02
|
$34,592
|
FALLS, KELLY
|
UNIVERSITY OF IOWA
|
|
Analysis of the novel phenomenon of antibody-mediated fratricide in Acute Myeloid Leukemia
|
5F30CA217006-02
|
$49,524
|
FATEHCHAND, KAVIN
|
OHIO STATE UNIVERSITY
|
|
The role of PRAME in promoting metastasis in uveal melanoma
|
5F30CA206430-03
|
$49,524
|
FIELD, MATTHEW
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Genome editing to determine functional consequences of thousands of potentially pathogenic variants
|
5F30CA213728-02
|
$39,250
|
FINDLAY, GREGORY
|
UNIVERSITY OF WASHINGTON
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|